“增免方”防治小儿复感116例临床观察

顾梯成; 曹兰芳; 濮存莹; 陈颖

您当前的位置：

首页 >

文章列表页 >

“增免方”防治小儿复感116例临床观察

更新时间：2024-01-04

- “增免方”防治小儿复感116例临床观察
- Clinical Study on Treating of Repeated Respiratory Tract Infection in Children with Zengmian Prescription
- 中国实验方剂学杂志 1997年3卷第1期页码：31-33
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R725.6
- 纸质出版日期：1997
- 稿件说明：
移动端阅览
顾梯成, 曹兰芳, 濮存莹, 等. “增免方”防治小儿复感116例临床观察[J]. 中国实验方剂学杂志, 1997,3(1):31-33.

Clinical Study on Treating of Repeated Respiratory Tract Infection in Children with Zengmian Prescription[J]. Chinese journal of experimental traditional medical formulae, 1997, 3(1): 31-33.
顾梯成, 曹兰芳, 濮存莹, 等. “增免方”防治小儿复感116例临床观察[J]. 中国实验方剂学杂志, 1997,3(1):31-33. DOI：

Clinical Study on Treating of Repeated Respiratory Tract Infection in Children with Zengmian Prescription[J]. Chinese journal of experimental traditional medical formulae, 1997, 3(1): 31-33. DOI：

摘要

运用平补阴阳法设计“增免方”防治小儿复感116例

对照组32例用丙种球蛋白

结果两组分别取得94.8%和68.75%的防治效果。治疗组用药后

血清IgG、IgA

唾液SIgA和血Hb明显提高

PHA皮试反应增强

与治疗前比较

有显著性差异。而对照组上述指标治疗前后

无显著性差异。

Abstract

Zengmian prescription was formulated based on the theory of mild reinforcing Yin Yang.The observation on 116 cascs in the group treated with the prescription revealed that this prescription could counteract respiratory tract infection

with total effective rate being 94.8%

which was higher than 68.75% in the control group.After the treatment

the indexes of cell-ular immunity

and IgG、IgA、SIgA and hemoglobin were all improved

while there were no changes in the immunological indexes following exposure to gamma globulin as a reference drug.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据